Cellular and metabolic evaluation of (hydroxyproline(3))-GIP as new stable GIP receptor antagonist with antidiabetic potential

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)0661
JournalDiabetologia
Volume49
Issue numberSuppl.
Publication statusPublished - Sep 2006

Bibliographical note

42nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Copenhagen,
DENMARK, SEP 14-17, 2006

Cite this